Innocoll's Take Private Round

Innocoll raised a round of funding on July 24, 2017. Investors include Gurnet Point Capital.

Innocoll is a global commercial stage specialty pharmaceutical company with late stage development programs targeting areas of significant unmet medical need. The company develops and manufactures a r…

Articles about Innocoll's Take Private Round: